Actionable news
0
All posts from Actionable news
Actionable news in REGN: Regeneron Pharmaceuticals, Inc.,

UPDATE 2-Regeneron raises Eylea sales growth estimates again

* Expects FY Eylea sales growth between 50-55 pct

* Praluent U.S. sales $4 mln in Q3

* Shares rise 3.8 pct premarket (Adds forecast, background)

Nov 4 (Reuters) - Regeneron Pharmaceuticals Inc raised Eylea sales growth forecast for the third time this year, after surging sales of the eye drug helped the company beat quarterly profit and revenue estimates.

The company's shares were up 3.8 percent at $599 in premarket trading on Wednesday.

Eylea, an injectable drug, has been garnering investor attention since 2011 when it was first...


More